The Pharmacy Times® Gastrointestinal resource center provides news and articles centered around the FDA approved drugs in gastroenterology, as well as links to condition-specific resources, and videos and other content.
What can we help you find?
According to a study published in Genome Medicine, the disruption of gut bacteria through the use of antibiotics soon after birth has the ability to affect the immune system’s process of maturation.
Mylan plans to launch adalimumab-fkjp in the United States in July 2023.
According to an online survey of more than 53,000 Americans using PPIs, once or twice daily use significantly increases the likelihood of a positive test for COVID-19.
According to a recent study published in Gut, inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn disease, is associated with a more than doubled likelihood of developing dementia.
Reducing salt intake to a healthier level appears to be beneficial for the gut microbiome and blood pressure, especially in females with untreated hypertension, according to researchers at the Medical College of Georgia at Augusta University.
According to a recent study, diet can affect the outcome of chemotherapy due to microbes in the gut that can trigger changes in a patient’s response to drugs.
The researchers analyzed the National Health Interview Survey 2015 to determine the food intake and frequency of consumption for US adults with IBD.
In a new study, researchers analyzed gut microbiota to understand further the links between gut health and obesity.
Why was a patient prescribed something normally used for stomach problems to help her produce breastmilk?
Generic products featured in the April 2020 issue.
A survey conducted between March 30 to April 6 by InsightRx found that implementing the new vancomycin guidelines into the pharmacy community is as important as the coronavirus disease 2019 (COVID-19) in the healthcare system.
The clinical practice update incorporates emerging evidence and available guidance for patients with IBD.